Revue Francaise d Allergologie

Scope & Guideline

Connecting Researchers and Practitioners in Allergology

Introduction

Welcome to your portal for understanding Revue Francaise d Allergologie, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageFrench
ISSN1877-0320
PublisherELSEVIER MASSON, CORP OFF
Support Open AccessNo
CountryFrance
TypeJournal
Convergefrom 2009 to 2024
AbbreviationREV FR ALLERGOL / Rev. Fr. Allergol.
Frequency8 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE

Aims and Scopes

The Revue Francaise d'Allergologie serves as a vital platform for disseminating research and knowledge in the field of allergy and immunology. Its aim is to enhance understanding of allergenic responses, improve diagnostic methods, and advance therapeutic strategies for allergic conditions. The journal focuses on both clinical and experimental studies, emphasizing real-world applications and patient-centered outcomes.
  1. Clinical Allergology:
    The journal publishes studies related to the diagnosis, management, and treatment of various allergic conditions, including asthma, food allergies, and allergic rhinitis.
  2. Epidemiological Research:
    It features epidemiological studies that investigate the prevalence, risk factors, and socio-economic impacts of allergies across different populations.
  3. Immunotherapy and Treatment Innovations:
    Research on novel therapies, including oral immunotherapy and biologics, is a core focus, aiming to provide insights into effective management of allergic diseases.
  4. Pathophysiological Mechanisms:
    Investigations into the underlying mechanisms of allergic reactions, including immunological responses and molecular interactions, are frequently explored.
  5. Patient Quality of Life and Psychosocial Aspects:
    The journal emphasizes studies that assess the quality of life of patients with allergies, considering the psychological and social dimensions of living with allergic conditions.
  6. Environmental and Dietary Influences:
    Research exploring the impact of environmental changes, dietary habits, and climate on allergy prevalence and management is highlighted.
The Revue Francaise d'Allergologie has shown a dynamic evolution in its publication trends, with several emerging themes gaining prominence. These reflect current societal health challenges and advancements in the field of allergy research.
  1. Personalized Medicine in Allergy Treatment:
    There is a growing focus on personalized approaches to allergy treatment, including tailored therapies based on individual patient profiles and responses.
  2. Impact of Climate Change on Allergies:
    Recent studies are increasingly addressing how climate change affects allergen levels, distribution, and the prevalence of allergic diseases, highlighting a timely and critical area of research.
  3. Food Allergy Management and Education:
    Emerging themes include innovative strategies for managing food allergies, with an emphasis on patient education and individualized care plans.
  4. Biologics and Advanced Therapies:
    Research on biologic treatments for severe allergic conditions is on the rise, reflecting advancements in targeted therapy and immunomodulation.
  5. Mental Health and Allergy Interactions:
    There is an increasing awareness of the psychosocial impact of allergies, with studies focusing on mental health issues related to living with allergic conditions.
  6. Integration of Technology in Allergy Management:
    The use of digital health tools and telemedicine in allergy management is becoming more prevalent, as researchers explore their effectiveness in patient care.

Declining or Waning

While the Revue Francaise d'Allergologie continues to be a leading journal in the field, certain themes appear to be waning in prominence. This decline may reflect shifts in research priorities or advancements in knowledge that have led to reduced focus on these areas.
  1. Traditional Allergen Testing Methods:
    As novel diagnostic tools and molecular techniques gain traction, traditional methods for allergen testing may be receiving less attention in recent publications.
  2. Generalized Allergy Awareness Campaigns:
    Research on broad public awareness campaigns for allergies seems to be declining, possibly due to a shift towards more targeted and specific educational initiatives.
  3. Historical Perspectives on Allergy:
    Fewer studies appear to focus on the historical evolution of allergy management and understanding, indicating a shift towards contemporary issues and modern therapeutic approaches.
  4. Occupational Allergies:
    There seems to be a reduced emphasis on research specifically addressing occupational allergies, potentially overshadowed by broader environmental and lifestyle factors.
  5. Food Allergy Diversity Studies:
    While food allergies remain a significant topic, the exploration of diverse food allergies without specific context may be decreasing, as the focus shifts to more prevalent allergens.

Similar Journals

ALLERGOLOGIA ET IMMUNOPATHOLOGIA

Connecting Researchers to Transform Allergy and Immunology Insights
Publisher: CODON PUBLICATIONSISSN: 0301-0546Frequency: 6 issues/year

ALLERGOLOGIA ET IMMUNOPATHOLOGIA is a distinguished academic journal dedicated to the field of immunology and allergy, published by CODON PUBLICATIONS, based in Singapore. With its ISSN 0301-0546 and E-ISSN 1578-1267, this journal aims to provide an open platform for researchers and practitioners to share their findings, emphasizing topics related to immunopathology and respiratory health. Covering a broad scope from 1973 to 2024, it currently holds a notable position in several category quartiles, including Q3 in Immunology and Allergy, and Q3 in Pulmonary and Respiratory Medicine as of 2023. Despite the absence of an open access option, the journal maintains an essential role in disseminating pivotal research, reflected in its Scopus rankings that position it within the core of its discipline. With an impact factor acknowledging the significance of its contributions, ALLERGOLOGIA ET IMMUNOPATHOLOGIA continues to be a vital resource for ongoing education and advancement in immunological and allergic research.

World Allergy Organization Journal

Innovating Solutions for Allergic Diseases Worldwide
Publisher: ELSEVIERISSN: 1939-4551Frequency: 12 issues/year

World Allergy Organization Journal is a premier open-access publication dedicated to advancing the understanding and treatment of allergic diseases and related conditions. Published by ELSEVIER, this journal boasts a commendable impact factor and ranks in the second quartile for both Immunology and Allergy, as well as the first quartile in Pulmonary and Respiratory Medicine. Since its inception as an open-access journal in 2008, it has consistently aimed to provide a credible platform for researchers, clinicians, and students to disseminate original research, reviews, and clinical studies. With its emphasis on high-quality scholarship and practical applications, the World Allergy Organization Journal plays a crucial role in bridging theoretical knowledge with clinical practice, making significant contributions to the fields of immunology, allergy, and respiratory medicine. The journal is particularly notable for its accessibility to a global audience, exemplified by its open-access model since 2008, promoting a wider exchange of ideas and innovations across borders.

Allergy Asthma and Clinical Immunology

Elevating the standards of clinical immunology research.
Publisher: BMCISSN: 1710-1492Frequency: 1 issue/year

Allergy Asthma and Clinical Immunology, a pioneering open access journal published by BMC, has been at the forefront of immunological research since its inception in 2005. With an ISSN of 1710-1492, this UK-based journal has established a significant presence in the fields of Immunology, Allergy, and Pulmonary and Respiratory Medicine, achieving notable quartile rankings such as Q2 in Immunology and Allergy in 2023. It plays a crucial role in disseminating high-quality research that advances our understanding of allergy and asthma, making substantial contributions to clinical practices and public health. The journal embraces the principles of Open Access, allowing researchers, professionals, and students from around the globe to access its content freely, thus facilitating knowledge sharing and collaboration within the scientific community. As it converges towards 2024, Allergy Asthma and Clinical Immunology continues to attract impactful studies that drive innovation and improve patient care in the face of rapidly evolving challenges in immunological health.

Asia Pacific Allergy

Connecting Dermatology and Immunology for Better Patient Care
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2233-8276Frequency: 4 issues/year

Asia Pacific Allergy, published by Lippincott Williams & Wilkins, is a prominent academic journal dedicated to advancing research and clinical practice in the fields of dermatology, immunology, and allergy. With its ISSN 2233-8276 and E-ISSN 2233-8268, the journal provides a platform for innovative studies and reviews that cater to an international audience of researchers, healthcare professionals, and students involved in allergy and related disorders. Although it does not currently offer open access to its publications, the journal's robust output from 2015 to 2017 and its ongoing contribution to the literature from 2021 to 2024 showcase the evolving landscape of allergy research in the Asia Pacific region. Recognized in the 2023 Journal Citation Reports, it holds a Q2 ranking in Dermatology and a Q3 ranking in Immunology and Allergy, while its Scopus ranks further emphasize its significance within these domains, positioning it among the top journals in the field. As a source of cutting-edge research, Asia Pacific Allergy plays a vital role in fostering collaboration and knowledge dissemination, ultimately assisting in the betterment of patient care and treatment strategies across the region.

Alergologia Polska-Polish Journal of Allergology

Empowering the allergic community with open access knowledge.
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 2353-3854Frequency: 4 issues/year

Alergologia Polska - Polish Journal of Allergology, published by TERMEDIA PUBLISHING HOUSE LTD, is a distinguished academic journal dedicated to advancing the field of allergy research and treatment. With the ISSN 2353-3854, this journal serves as an essential resource for professionals, researchers, and students alike, offering a platform for the dissemination of novel findings and comprehensive reviews in allergic diseases. The journal emphasizes open access to ensure widespread availability and engagement within the scientific community. Alergologia Polska aims to enhance the understanding of allergy mechanisms, diagnostics, and management strategies, fostering collaboration and innovation among experts in the field. Set against the vibrant backdrop of Poznań, Poland, this publication not only highlights clinical and experimental research but also promotes interdisciplinary discussions that are pivotal for tackling complex allergic conditions globally.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Fostering Innovation in Allergy, Asthma, and Immunology
Publisher: ELSEVIER SCIENCE INCISSN: 1081-1206Frequency: 12 issues/year

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY is a premier peer-reviewed journal published by Elsevier Science Inc, dedicated to advancing the fields of allergy, asthma, and immunology. With its roots dating back to 1995 and with a focus on high-impact research, this journal has established itself as a leading platform for the dissemination of original research, reviews, and clinical studies within these critical areas. The journal boasts an impressive impact factor, supporting its Q2 ranking in both Immunology and Allergy, as well as in Pulmonary and Respiratory Medicine, indicating its significant contribution to the scientific community. Although it does not currently offer open access options, its comprehensive coverage and rigorous peer-review process ensure that published articles are of the highest quality, making it an invaluable resource for researchers, clinicians, and students alike. The Scopus rankings reflect its esteemed position in the academic landscape, providing professionals with access to cutting-edge developments and insights into the management and treatment of allergic and respiratory conditions.

Alergia Astma Immunologia

Innovating solutions for respiratory and immunological challenges.
Publisher: Asthma and Allergy Patients Support OrganizationISSN: 1427-3101Frequency: 4 issues/year

Alergia Astma Immunologia is a dedicated journal focusing on the interdisciplinary fields of immunology and respiratory medicine, published by the Asthma and Allergy Patients Support Organization in Poland. With a commitment to advancing research and sharing knowledge, this journal serves as a platform for scholars and practitioners to discuss critical issues and recent advances in allergy, asthma, and immunological disorders. Despite being in Category Quartiles Q4 for both Immunology and Allergy and Pulmonary and Respiratory Medicine, its importance is highlighted by its continuous publication since 2000, providing a historical perspective on evolving scientific insights. Researchers and clinicians alike benefit from accessing novel findings and case studies that contribute to improved patient outcomes and innovative therapeutic strategies. While the journal currently offers limited open access, its commitment to providing high-quality, peer-reviewed content ensures its relevance in the academic discourse within these vital areas of health science. The journal aims to foster collaboration, stimulate research interest, and promote evidence-based practices within the professional community.

Egyptian Journal of Pediatric Allergy and Immunology

Championing advancements in the understanding of pediatric allergies.
Publisher: EGYPTIAN SOC PEDIATRIC ALLERGY & IMMUNOLOGYISSN: 1687-1642Frequency: 2 issues/year

Welcome to the Egyptian Journal of Pediatric Allergy and Immunology, a leading academic platform dedicated to the advancement of knowledge in the field of pediatric allergy and immunology. Published by the prestigious Egyptian Society of Pediatric Allergy & Immunology, this journal aims to address the pressing challenges and breakthroughs in the diagnosis, treatment, and management of allergic diseases in children. As a crucial resource for researchers, healthcare professionals, and students, it focuses on disseminating high-quality, peer-reviewed articles that contribute to the global understanding of allergic conditions and immunological responses in pediatric populations. Although the journal is currently not an Open Access publication, it provides a valuable gateway to research findings that can shape clinical practice and influence future investigations. With an emphasis on contributing to improved healthcare outcomes for children suffering from allergy and immunology disorders, the Egyptian Journal of Pediatric Allergy and Immunology stands out as an essential reference in the field.

Postepy Dermatologii i Alergologii

Championing open access to vital health insights.
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 1642-395XFrequency: 6 issues/year

Postepy Dermatologii i Alergologii is a distinguished Open Access journal published by TERMEDIA PUBLISHING HOUSE LTD, dedicated to advancing the fields of Dermatology and Immunology and Allergy. Since its inception in 2003, this journal has served as a vital platform for researchers and practitioners alike, promoting knowledge sharing and collaboration in Poland and beyond. With a current impact ranking placing it in the Q3 quartile for both Dermatology and Immunology and Allergy categories, it plays a significant role in contributing to academic discourse within these fields. The journal is indexed in Scopus, with respectable rankings reflecting its relevance and quality—#65/142 in Dermatology and #163/233 in Immunology and Allergy. Researchers are encouraged to explore a vast array of innovative studies and reviews, making it an essential resource for anyone seeking to stay at the forefront of dermatological and allergic research. For those interested in discovering groundbreaking findings and contributing to the ongoing dialogue in these disciplines, Postepy Dermatologii i Alergologii offers not only free accessibility but also a commitment to scholarly excellence.

Allergy Asthma & Respiratory Disease

Connecting disciplines for a healthier tomorrow.
Publisher: KOREAN ACAD ASTHMA ALLERGY & CLINICAL IMMUNOLOGYISSN: 2288-0402Frequency: 4 issues/year

Allergy Asthma & Respiratory Disease is a pioneering journal dedicated to advancing research and clinical practice in the fields of allergy, asthma, and related respiratory diseases. Published by the esteemed Korean Academy of Asthma Allergy & Clinical Immunology, this journal aims to disseminate high-quality, peer-reviewed articles that contribute to the understanding, diagnosis, and treatment of these prevalent health issues. Although it operates under a subscription model, it maintains a robust reputation for being a pivotal resource in respiratory health, attracting authors and researchers worldwide. The journal emphasizes interdisciplinary approaches and encourages submissions that span from molecular biology to public health perspectives, making it a vital platform for professionals, researchers, and students eager to deepen their knowledge in respiratory medicine. With a commitment to fostering academic discourse in South Korea and beyond, Allergy Asthma & Respiratory Disease is positioned as a significant contributor to the global conversation on respiratory health.